Effects of a casein hydrolysate prepared from Aspergillus oryzae protease on adjuvant arthritis in rats

Bioscience, Biotechnology and Biochemistry

Volumn 72, Issue 8, 2008, Pages 1983-1991

  Hatori, Michio ^a   Ohki, Kohji ^a   Hirano, Shin Ichi ^b   Yang, Xiao Ping ^b   Kuboki, Hiroshi ^b   Abe, Chiyuki ^c  

^a CALPIS Co Ltd   (Japan)

^b Mercian Cleantec Corporation   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant arthritis; Aspergillus oryzae protease; Casein hydrolysate; Nitric oxide; Prostaglandin E2

Indexed keywords

NITRIC OXIDE;

ADJUVANT ARTHRITIS; ASPERGILLUS ORYZAE PROTEASE; CASEIN HYDROLYSATE; PROSTAGLANDIN E2;

CASEIN;

CASEIN; CASEIN HYDROLYSATE; IBUPROFEN; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL; ARTHRITIS; ARTICLE; ASPERGILLUS ORYZAE; BIOSYNTHESIS; BODY WEIGHT; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; PATHOLOGY; RAT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ASPERGILLUS ORYZAE; BODY WEIGHT; CASEINS; DINOPROSTONE; FEMALE; IBUPROFEN; NITRIC OXIDE; RATS;

ANIMALIA; ASPERGILLUS ORYZAE; RATTUS;

EID: 51049089729     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.70792     Document Type: Article

References (36)

1. Firestein, G. S., Alvaro-Garcia, J. M., and Maki, R., Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol., 144, 3347-3353 (1990).
2. Chen, E., Keystone, E. C., and Fish, E. N., Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum., 36, 901-910 (1993).
3. Keystone, E. C., Gladmann, D. D., Buchanan, R., Cane, D., and Poplonski, L., Impaired antigen specific suppressor cell activity in patients with rheumatoid arthritis. Arthritis Rheum., 23, 1246-1250 (1980).
4. Schuna, A. A., and Megeff, C., New drugs for the treatment of rheumatoid arthritis. Am. J. Health Syst. Pharm., 57, 225-234 (2000).
5. Santana-Sabagun, E., and Weisman, M. H., Nonsteroidal anti-inflammatory drugs. In "Kelly's Textbook of Rheumatology" Vol. 1, eds. Ruddy, S., Harris, J. E. D., Sledge, C. B., Budd, R. C., and Sergent, J. S., W.B. Saunders Company, Philadelphia, pp. 799-822 (2001).
6. Shiokawa, Y., Horiuchi, Y., Mizushima, Y., Kageyama, T., Shichikawa, K., Ofuji, T., Honma, M., Yoshizawa, H., Abe, C., and Ogawa, N., A multicenter double-blind controlled study of lobenzarit, a novel immunomodulator, in rheumatoid arthritis. J. Rheumatol., 11, 615-623 (1984).
7. Yasuda, M., Nonaka, S., Wada, T., Yamamoto, M., Shiokawa, S., Suenaga, Y., and Nobunaga, M., Additive two DMARD therapy of the patients with rheumatoid arthritis. Clin. Rheumatol., 13, 446-454 (1994).
8. Hua, J., Suguro, S., Hirano, S., Sakamoto, K., and Nagaoka, I., Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm. Res., 54, 127-132 (2005).
9. Abe, C., Fujita, K., Kikuchi, E., Hirano, S., Kuboki, H., Yamashita, A., Hashimoto, H., Mori, S., and Okada, M., Effects of α-linked galactooligosaccharide on adjuvant-induced arthritis in wistar rats and type II collagen-induced arthritis in DBA1/J mice. Int. J. Tissue React., 26, 65-73 (2004).
10. Hayashida, K., Kaneko, T., Takeuchi, T., Shimizu, H., Ando, K., and Harada, E., Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci., 66, 149-154 (2004).
11. Teschemacher, H., Kock, G., and Brantl, V., Milk protein-derived opioid receptor ligands. Biopolymers, 43, 99-117 (1997).
12. Lahov, E., and Regelson, E., Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem. Toxicol., 34, 131-145 (1996).
13. Kim, S. K., Kim, Y. T., Byun, H. G., Nam, K. S., Joo, D. S., and Shahide, F., Isolation and characterization of antioxidative peptides from gelatin hydrolyzate of Alaska Pollack skin. J. Agric. Food Chem., 49, 1984-1989 (2001).
14. Maruyama, S., Nakagomi, K., Tomizuka, N., and Suzuki, H., Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. Agric. Biol. Chem., 49, 1405-1409 (1985).
15. Yamamoto, N., Akino, A., and Takano, T., Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci., 77, 917-922 (1994).
16. Mizuno, S., Nishimura, S., Matsuura, K., Gotou, T., and Yamamoto, N., Release of short and proline-rich antihypertensive peptides from casein hydolysate with an Aspergillus oryzae protease. J. Dairy Sci., 87, 3183-3188 (2004).
17. Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S., and Takano, T., Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci., 78, 777-783 (1995).
18. Nakamura, Y., Yamamoto, N., Sakai, K., and Takano, T., Anti-hypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme inhibitors. J. Dairy Sci., 78, 1253-1257 (1995).
19. Abe, C., Hirano, S., Wakazono, K., Mase, T., Yamamoto, R., Matsufuji, M., Sakata, N., Agata, N., Iguchi, H., Ishizuka, M., and Takeuchi, T., Effects of cytogenin on spontaneous arthritis in MRL/l mice and on pritane-induced arthritis (PIA) in DBA/1J mice. Int. J. Tissue React., 17, 175-180 (1995).
20. Mohr, W., and Wild, A., Adjuvant arthritis. Arzneimitterfolschung, 26, 1860-1866 (1976).
21. Gryglewski, R. J., Some experimental models for the study of inflammation and anti-inflammatory drugs. Agents Actions Suppl., 17-23 (1977).
22. Higuchi, S., Osada, Y., Shioiri, Y., Tanaka, N., and Otomo, S., Effects of anti-inflammatory drugs on the lame walking reaction in adjuvant-induced edematous rats. Nippon Yakurigaku Zasshi (in Japanese), 84, 243-249 (1984).
23. Otomo, S., Higuchi, S., Nakaike, S., Tarumoto, Y., Kimura, M., Sasajima, M., and Ohzeki, M., Studies of D-penicillamine (5): effects on rat adjuvant arthritis. Nippon Yakurigaku Zasshi (in Japanese), 78, 145-162 (1981).
24. Fujimura, H., Hiramatsu, Y., Tamura, Y., Yanagihara, M., Koda, A., Nagai, H., Uda, K., Iso, T., and Yamauchi, H., Pharmacological studies of new sulfhydryl compounds 2-mercapto-2-methylpropanoyl-L-cysteine (SA96). I. Evaluation of anti-rheumatic action. Nippon Yakurigaku Zasshi (in Japanese), 76, 117-129 (1980).
25. Abe, C., Kikukawa, T., Komatsu, Y., Goto, M., Fujihira, E., and Hirano, S., Quality of arthritis: early articular lesions in experimental animal models for arthritis. Japanese J. Inflamm. (in Japanese), 15, 395-399 (1995).
26. Agata, N., Hirano, S., Abe, C., Nakashima, T., Tsuchiya, A., Kumagai, H., Isshiki, K., Yoshioka, T., Ishizuka, M., and Takeuchi, T., Suppression of type II collagen-induced arthritis by a new isocoumarin, NM-3. Res. Commun. Mol. Pathol. Pharmacol., 108, 297-309 (2000).
27. Jang, D., and Murrell, G. A. C., Nitric oxide in arthritis. Free Radic. Biol. Med., 24, 1511-1519 (1998).
28. McInnes, I. B., Leung, B. P., Field, M., Wei, X. Q., Huang, F. P., Sturrock, R. D., Kinninmonth, A., Weidner, J., Mumford, R., and Liew, F. Y., Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med., 184, 1519-1524 (1996).
29. Lalenti, A., Moncada, S., and Rosa, M. D., Modulation of adjuvant arthritis by endogenous nitric oxide. Br. J. Pharmacol., 110, 701-706 (1993).
30. Connor, J. R., Manning, P. T., and Settle, S. L., Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide. Eur. J. Pharmacol., 273, 15-24 (1995).
31. Crofford, L. J., Wilder, R. L., Ristimaki, A. P., Sano, H., Remmers, E. F., Epps, H. R., and Hla, T., Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids. J. Clin. Invest., 93, 1095-1101 (1994).
32. Fournier, T., Fadok, V., and Henson, P. M., Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxigenase-2 expression and prostaglandin E2 synthesis. J. Biol. Chem., 272, 31065-31072 (1997).
33. Spangler, R. S., Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy. Semin. Arthritis Rheum., 26, 435-446 (1996).
34. Kawahara, T., Katayama, D., and Otani, H., Effect of β-casein (1-28) on proliferative responses and secretory functions of human immunocompetent cell lines. Biosci. Biotechnol. Biochem., 68, 2091-2095 (2004).
35. Biziulevicius, G. A., Kislukhina, O. V., Kazlauskaite, J., and Zukaite, V., Food-protein enzymatic hydrolysates possess both antimicrobial and immunostimulatory activities: a cause and effect theory of bifunctionality. FEMS Immunol. Med. Microbiol., 46, 131-138 (2006).
36. Kazlauskaite, J., Biziulevicius, G. A., Zukaite, V., Biziuleviciene, G., Miliukiene, V., and Siaurys, A., Oral tryptic casein hydrolysate enhances phagocytosis by mouse peritoneal and blood phagocytic cells but fails to prevent induced inflammation. Int. Immunopharmacol., 5, 1936-1944 (2005).